搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
2 天
PROTAC风云:辉煌背后的失落与希望
在3月12日那天,纽约华尔街的股市仿佛被暴风雪袭击,Arvinas的股价急剧下跌,无疑是PROTAC(蛋白降解靶向嵌合体)技术历史上一个重要的转折点。曾几何时,这家被寄予厚望、认为会颠覆传统小分子药物市场的生物制药公司,却在新药Vepdegestrant的三期临床数据公布后,股价以52.73%的断崖式暴跌,将其昔日的光环一扫而空。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Survives 95 days at sea
US mulls travel ban
Staff placed on leave
North Macedonia deadly fire
Iran denies US claims
Oklahoma wildfires
To review F-35 jets purchase
Electrical fire halts show
Man wins $50M over burns
Kellogg's envoy role reduced
Israeli attack in Gaza
US launches strikes in Yemen
Texas measles outbreak
Crew-10 arrives at ISS
Withdraws nomination
Chiefs sign Tillery
Second protester arrested
Severe weather outbreak
US expels SA ambassador
Gold rises to new heights
Pleads not guilty
Kupp signs with Seahawks
Trump signs funding bill
ISIS leader killed in Iraq
Cuba suffers power outage
Coffee creamer recall
Syed formally resentenced
Felony gun possession arrest
Wins longest-ever Iditarod
RU, UKR launch attacks
Laceration hazard recall
反馈